Back to VA VANGUARD CAPITAL MANAGEMENT LLC

RNARNA
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in ATRIUM THERAPEUTICS INC

VANGUARD CAPITAL MANAGEMENT LLC holds 730,831 shares of RNA (ATRIUM THERAPEUTICS INC), worth $9.8M as of 2026-Q2. The position was increased (+16.6% shares). RNA represents 0.0% of VANGUARD CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$9.8M

Current Shares

730,831

Total Value Change

+$1.4M

Total Shares Change

+103,962

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
730,831
+16.6%
$9.8M0.0%$13.45
32
2026-Q1
New
626,869
-
$8.4M0.0%$15.67
38

Other major holders of RNA: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used